Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
GeriPal
DECEMBER 15, 2022
In an article in the NEJM (a published article this time, wonder of wonders!) Jason Karlawish and Ken Covinsky appeared first on A Geriatrics and Palliative Care Podcast for Every Healthcare Professional. But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No Eric: And Alex, who do we have with us today?
Let's personalize your content